Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gepotidacin in Acute Cystitis (SIS)
NCT06597344Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gepotidacin in acute cystitis, sponsored by GSK. Started Oct 2024; status: completed.
02
Drugs
gepotidacin
03
Conditions
acute cystitis
Beyond the preview
Go deeper on NCT06597344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06597344.